These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21228137)

  • 21. Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine.
    Clements ML; Murphy BR
    J Clin Microbiol; 1986 Jan; 23(1):66-72. PubMed ID: 3700610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intranasal and sublingual delivery of inactivated polio vaccine.
    Kraan H; Soema P; Amorij JP; Kersten G
    Vaccine; 2017 May; 35(20):2647-2653. PubMed ID: 28400164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the immune response following subcutaneous versus intranasal modified-live virus booster vaccination against bovine respiratory disease in pre-weaning beef calves that had received primary vaccination by the intranasal route.
    Palomares RA; Bittar JHJ; Woolums AR; Hoyos-Jaramillo A; Hurley DJ; Saliki JT; Ferrer MS; Bullington AC; Rodriguez A; Murray T; Thoresen M; Jones K; Stoskute A
    Vet Immunol Immunopathol; 2021 Jul; 237():110254. PubMed ID: 34034143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholera toxin B stimulates systemic neutralizing antibodies after intranasal co-immunization with measles virus.
    Muller CP; Beauverger P; Schneider F; Jung G; Brons NH
    J Gen Virol; 1995 Jun; 76 ( Pt 6)():1371-80. PubMed ID: 7782766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucosal antibodies to human cytomegalovirus glycoprotein B occur following both natural infection and immunization with human cytomegalovirus vaccines.
    Wang JB; Adler SP; Hempfling S; Burke RL; Duliège AM; Starr SE; Plotkin SA
    J Infect Dis; 1996 Aug; 174(2):387-92. PubMed ID: 8699071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measles immunity and response to revaccination among secondary school children in Cumbria.
    Calvert N; Cutts F; Irving R; Brown D; Marsh J; Miller E
    Epidemiol Infect; 1996 Feb; 116(1):65-70. PubMed ID: 8626005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Local and Systemic Immunity against Respiratory Syncytial Virus Induced by a Novel Intranasal Vaccine. A Randomized, Double-Blind, Placebo-controlled Clinical Trial.
    Ascough S; Vlachantoni I; Kalyan M; Haijema BJ; Wallin-Weber S; Dijkstra-Tiekstra M; Ahmed MS; van Roosmalen M; Grimaldi R; Zhang Q; Leenhouts K; Openshaw PJ; Chiu C
    Am J Respir Crit Care Med; 2019 Aug; 200(4):481-492. PubMed ID: 30753101
    [No Abstract]   [Full Text] [Related]  

  • 28. [Intranasal revaccination of children with live measles vaccine: development of local immunity].
    Liashenko VA; Iuminova NV; Krasnova VP; Glazkova NV; Svirina VS
    Vopr Virusol; 1999; 44(3):124-6. PubMed ID: 10392436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rubella immunization of volunteers via the respiratory tract.
    Ganguly R; Ogra PL; Regas S; Waldman RH
    Infect Immun; 1973 Oct; 8(4):497-502. PubMed ID: 4200537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mucosal immune response in newborn Holstein calves that had maternally derived antibodies and were vaccinated with an intranasal multivalent modified-live virus vaccine.
    Hill KL; Hunsaker BD; Townsend HG; van Drunen Littel-van den Hurk S; Griebel PJ
    J Am Vet Med Assoc; 2012 May; 240(10):1231-40. PubMed ID: 22559114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel intranasal Protollin-based measles vaccine induces mucosal and systemic neutralizing antibody responses and cell-mediated immunity in mice.
    Chabot S; Brewer A; Lowell G; Plante M; Cyr S; Burt DS; Ward BJ
    Vaccine; 2005 Feb; 23(11):1374-83. PubMed ID: 15661386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neonatal immunization with a Sindbis virus-DNA measles vaccine induces adult-like neutralizing antibodies and cell-mediated immunity in the presence of maternal antibodies.
    Capozzo AV; Ramírez K; Polo JM; Ulmer J; Barry EM; Levine MM; Pasetti MF
    J Immunol; 2006 May; 176(9):5671-81. PubMed ID: 16622037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination.
    Hirabayashi Y; Kurata H; Funato H; Nagamine T; Aizawa C; Tamura S; Shimada K; Kurata T
    Vaccine; 1990 Jun; 8(3):243-8. PubMed ID: 2363302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The sequential appearance of antibody and immunoglobins in nasal secretion after immunization of volunteers with live and inactivated influenza B virus vaccines.
    Downie JC
    J Hyg (Lond); 1973 Sep; 71(3):433-45. PubMed ID: 4518342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?
    Tamura S; Ainai A; Suzuki T; Kurata T; Hasegawa H
    Jpn J Infect Dis; 2016; 69(3):165-79. PubMed ID: 27212584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Localized mucosal response to intranasal live attenuated influenza vaccine in adults.
    Barría MI; Garrido JL; Stein C; Scher E; Ge Y; Engel SM; Kraus TA; Banach D; Moran TM
    J Infect Dis; 2013 Jan; 207(1):115-24. PubMed ID: 23087433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetics of mouse antibody and lymphocyte responses during intranasal vaccination with a lipooligosaccharide-based conjugate vaccine.
    Hirano T; Jiao X; Chen Z; Van Waes C; Gu XX
    Immunol Lett; 2006 Nov; 107(2):131-9. PubMed ID: 17030407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A trial of the intranasal vaccination of adults against measles: the approaches to an alternative revaccination method].
    Liashenko VA; Iuminova NV; Krasnova VP
    Vopr Virusol; 1992; 37(2):107-9. PubMed ID: 1441428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucosal and systemic immune responses to measles virus haemagglutinin in mice immunized with a recombinant vaccinia virus.
    Etchart N; Wild F; Kaiserlian D
    J Gen Virol; 1996 Oct; 77 ( Pt 10)():2471-8. PubMed ID: 8887480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral vaccination with influenza hemagglutinin combined with human pulmonary surfactant-mimicking synthetic adjuvant SF-10 induces efficient local and systemic immunity compared with nasal and subcutaneous vaccination and provides protective immunity in mice.
    Kimoto T; Kim H; Sakai S; Takahashi E; Kido H
    Vaccine; 2019 Jan; 37(4):612-622. PubMed ID: 30553569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.